Resident physicians in the US are poorly informed about the management of upper respiratory tract infections

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.434, 2003-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Responsible Prescribing for Upper Respiratory Tract Infections

By Turnidge J.

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2065-2077

Adis International

Access to resources Recommend Favorite

Efficacy of Spiramycin as an Alternative to Amoxicillin in the Treatment of Acute Upper Respiratory Tract Infections

By Bunnag C.

Clinical Drug Investigation, Vol. 15, Iss. 6, 1998-06 ,pp. : 461-466

Adis International

Access to resources Recommend Favorite

Moxifloxacin in respiratory tract infections

By Miravitlles Marc

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 283-293

Informa Healthcare

Access to resources Recommend Favorite

Viral Respiratory Tract Infections in Transplant Patients: Epidemiology, Recognition and Management

By Lee Ingi Barton Todd D.

Drugs, Vol. 67, Iss. 10, 2007-01 ,pp. : 1411-1427

Adis International

Access to resources Recommend Favorite

Reducing morbidity in respiratory tract infections

Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite